Expression of CD26 and DPP IV in T-acute lymphoblastic leukemia: Comparison of immunocytochemistry with enzyme cytochemistry

Neoplasma

Volumn 46, Issue 5, 1999, Pages 299-303

  Klobusicka M ^a   Babusikova O ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

CD26 antigen; Dipeptidyl peptidase IV; Immunophenotype; T acute lymphoblastic leukemia

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL PEPTIDASE IV;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CHILD; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LEUKEMIA CELL; MALE; T CELL LEUKEMIA; T LYMPHOCYTE;

EID: 0344771669     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. ANSORGE, S., SCHÖN, E.: Dipeptidyl peptidase IV (DPP IV), a functional marker of the T lymphocyte system. Acta Histochem., 82, 1987, 41-46.
2. ANSORGE, S., BUHLING, F., KAHNE, T., LENDECKEL, U., REINHOLD, D., TAGER, M., WRENGER, S.: CD26/dipeptidyl peptidase IV in lymphocyte growth regulation. Adv. Exp. Med. Biol., 421, 1997, 127-140.
3. BYLINKINA, V.S., LOKSHINA, L.A., SAMOJLOVA, R.S., LUBKOVA, O.N., GUREEVA, T.A., GOLUBEVA, N.V.: Dipeptidylpeptidase IV in human leukemic B-and T-cell. Biochem. Int., 28, 1992, 31-39.
4. CARBONE, A., COZZI, M., GLOGHINI, A., PINTO, A.: CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Hum. Pathol., 25, 1994, 1360-1365.
5. COZZI, M., GLOGHINI, A., VOLPE, R., CARBONE, A.: Immunohistocytochemical correlation of DAP IV-CD26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues. Br. J. Haematol., 75, 1990, 325-332.
6. DANG, N.H., TORIMOTO, Y., SUGITA, K., DALEY, J.F., SCHOW, P., PRADO, C., SCHLOSSMAN, S.F., MORIMOTO, CH.: Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J. Immunol., 145, 1990, 3963-3971.
7. DANG, N.H., TORIMOTO, Y., SHIMAMURA, K., TANAKA, T., DALEY, J.F., SCHLOSSMAN, S.F., MORIMOTO, CH.: 1F7 (CD26): A marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol., 147, 1991, 2825-2832.
8. HARTEL, S., GOSSRAU, R., HANSKI, C., REUTTER, W.: Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry. Histochemistry, 89, 1988, 151-161.
9. HEGEN, M., NIEDOBITEK, G., KLEIN, C.E., STEIN, H., FLEISCHER, B.: The cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J. Immunol., 144, 1990, 2908-2914.
10. KLOBUŠICKÁ, M., BABUŠÍKOVÁ, O.: Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression. Neoplasma, 45, 1998, 237-242.
11. KONDO, S., KOTANI, T., TAMURA, K., ARATAKE, H., UNO, H., TSUBOUCHI, H., INOUE, S., NIHO, Y., OHTAKI, S.: Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk.Res., 20, 1996, 357-363.
12. LOJDA, Z.: Studies on glycyl-proline naphthyl-amidase. I. Lymphocytes. Histochemistry, 54, 1977, 299-309.
13. LOJDA, Z.: Dipeptidyl peptidases of human lymphocytes. Czech. Med., 11, 1988, 181-194.
14. MATTERN, T., ANSORGE, S., FLAD, H.D., ULMER, A.J.: Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle. Immunobiology, 188, 1993, 36-50.
15. MORIMOTO, C., SCHLOSSMAN, S.F.: The structure and function of CD26 in the T-cell immune response. Immunol.Rev., 161, 1998, 55-70.
16. REINHERZ, E.L., KUNG, P.C., GOLDSTEIN, G., LEVEY, R.M., SCHLOSSMAN, S.F.: Discrete stages of human intrathymic differentiation: Analysis of normal thymocyte and leukemic lymphoblasts of T-cell lineage. Proc. Natl. Acad. Sci., USA, 77, 1980, 1588-1595.
17. REINHOLD, D., BANK, U., BUHLING, F., NEUBERT, K., MATTERN, T., ULMER, A.J., FLAD, H.D., ANSORGE, S.: Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology, 188, 1993, 403-414.
18. REINHOLD, D., BANK, U., BUHLING, F., KAHNE, T., KUNT, D., FAUST, J., NEUBERT, K., ANSORGE, S.: Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology, 192, 1994, 121-136.
19. RUIZ, P., ZACHARIEVICH, N., SHENKIN, M.: Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T lymphocyte populations. Clin. Diagn. Lab. Immunol., 5, 1998, 362-368.
20. RUIZ, P., ZACHARIEVICH, N., HAO, L., VICIANA, A.L., SHENKIN, M.: Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny. Clin. Immunol. Immunopathol., 88, 1998, 156-168.
21. SCHÖN, E., ANSORGE, S.: Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes. Biol. Chem. Hoppe Seyler, 371, 1990, 699-705.
22. TANAKA, T., CAMERINI, D., SEED, B., TORIMOTO, Y., DANG, N.H., KAMEOKA, J., DAHLBERG, H.N., SCHLOSSMAN, S.F., MORIMOTO, CH.: Cloning and functional expression of the T cell activation antigen CD26. J. Immunol., 149, 1992, 481-486.
23. TORIMOTO, Y., DANG, N.H., TANAKA, T., PRADO, C., SCHLOSSMAN, S.F., MORIMOTO, CH.: Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol., 29, 1992, 183-192.
24. UCKUN, F.M., GAYNON, P.S., SENSEL, M.G., NACHMAN, J., STEINHERZ, P.C., HUTCHINSON, R., BOSTROM, B.C., SATHER, H.N., REAMAN, G.H.: Clinical features and treatment outcome of childhood T lineage acute lymphoblastic leukemia according to the apparent maturation stage of T-lineage leukemic blasts: A Children's Cancer Group Study. J. Clin. Oncol., 15, 1997, 2214-2221.
25. ULMER, A.J., MATTERN, T., FELLER, A.C., HEYMANN, E., FLAD, H.-D.: CD26 antigen is a surface dipeptidyl peptidase IV (DPP IV) as characterized by monoclonal antibodies clone T II-19-4-7 and 4EL1C7. Scand. J. Immunol., 31, 1990, 429-435.